Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Prostanoids help regulate immune cells, affecting inflammation and cancer.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Lower MC2R expression may contribute to alopecia areata.

Two gene areas linked to male pattern baldness found, more research needed.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Extracellular ATP promotes growth, while adenosine inhibits it in Arabidopsis plants.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Testosterone affects stress hormone levels differently in adolescent and adult male rats.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

New compounds may help treat prostate issues without affecting androgen receptors.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

The inhibitor affects androgen metabolism but not ovarian function.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Wnt signaling is disrupted in asthma, affecting cell growth and inflammation.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

Androgen receptor differences may contribute to hair loss in AGA patients.

Progesterone reduces anxiety without needing progesterone receptors.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Women with hair loss have more androgen receptors in certain hair follicles.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

DGAT1 enzyme helps make diacylglycerols, waxes, and retinyl esters.